Synergistic apoptosis-inducing effects on A375 human melanoma cells of natural borneol and curcumin

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Chen, Jianping ^a   Li, Lin ^a   Su, Jianyu ^a,d   Li, Bing ^a   Chen, Tianfeng ^b,d   Wong, Yum Shing ^c  

^a SOUTH CHINA UNIVERSITY OF TECHNOLOGY   (China)

^b JINAN UNIVERSITY   (China)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d Guangdong Hua Qing Yuan Biological Technology Co Ltd   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ATM PROTEIN; BRCA1 PROTEIN; CASPASE 3; CASPASE 8; CASPASE 9; CURCUMIN; MITOGEN ACTIVATED PROTEIN KINASE; NATURAL BORNEOL; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN KINASE B; PROTEIN P53; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; BORNANE DERIVATIVE; ISOBORNEOL; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4;

A375 CELL LINE; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER GROWTH; CELL ASSAY; CELL CYCLE G1 PHASE; CELL POPULATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA DAMAGE; DNA FRAGMENTATION; DOWN REGULATION; DRUG STRUCTURE; ENZYME ACTIVATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MELANOMA CELL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; UPREGULATION; WESTERN BLOTTING; DRUG EFFECTS; DRUG POTENTIATION; MELANOMA; METABOLISM; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BORNANES; CELL LINE, TUMOR; CURCUMIN; DRUG SYNERGISM; HUMANS; MAP KINASE KINASE 4; MAP KINASE SIGNALING SYSTEM; MELANOMA; PROTO-ONCOGENE PROTEINS C-AKT; REACTIVE OXYGEN SPECIES;

EID: 84903398737     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101277     Document Type: Article

References (47)

1. Ammon HP, Wahl MA (1991) Pharmacology of curcuma longa Planta Med 57: 1-7.
2. Karunagaran D, Rashmi R, Santhosh Kumar TR (2005) Induction of apoptosis by curcumin and its implications for cancer therapy Curr Cancer Drug Tar 5: 117-129.
3. Zhang CY, Zhang L, Yu HX, Bao JD, Sun Z, et al. (2013) Curcumin inhibits invasion and metastasis in K1 papillary thyroid cancer cells. Food Chem 139: 1021-1028.
4. Shi MX, Cai QF, Yao LM, Mao YB, Ming YL, et al. (2006) Antiproliferation and apoptosis induced by curcumin in human ovarian cancer cells. Cell Biol Int 30: 221-226.
5. Yang YL, Ji C, Cheng L, He L, Lu CC, et al. (2012) Sphingosine kinase-1 inhibition sensitizes curcumin-induced growth inhibition and apoptosis in ovarian cancer cells. Cancer Sci 103: 1538-1545.
6. Wang WZ, Li L, Liu MY, Jin XB, Mao JW, et al. (2013) Curcumin induces fasL-related apoptosis through p38 activation in human hepatocellular carcinoma Huh7 cells. Life Sci 92: 352-358.
7. Watson JL, Hill R, Yaffe PB, Greenshields A, Walsh M, et al. (2010) Curcumin causes superoxide anion production and p53-independent apoptosis in human colon cancer cells. Cancer Lett 297: 1-8.
8. Yogosawa S, Yamada Y, Yasuda S, Sun Q, Takizawa K, et al. (2012) Dehydrozingerone, a structural analogue of curcumin, induces cell-cycle arrest at the G2/M phase and accumulates intracellular ROS in HT-29 human colon cancer cells. J Nature Prod 75: 2088-2093.
9. Chidambara Murthy KN, Jayaprakasha GK, Patil BS (2013) Citrus limonoids and curcumin additively inhibit human colon cancer cells. Food Funct 4: 803-810.
10. Einbond LS, Wu HA, Kashiwazaki R, He K, Roller M, et al. (2012) Carnosic acid inhibits the growth of ER-negative human breast cancer cells and synergizes with curcumin. Fitoterapia 83: 1160-1168.
11. Tong QS, Zheng LD, Lu P, Jiang FC, Chen FM, et al. (2006) Apoptosis-inducing effects of curcumin derivatives in human bladder cancer cells. Anti-Cancer Drug 17: 279-287.
12. Weir NM, Selvendiran K, Kutala VK, Tong L, Vishwanath S, et al. (2007) Curcumin induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by modulating Akt and p38MAPK. Cancer Biol Ther 6: 178-184. (Pubitemid 46641620)
13. Li M, Ma Y, Ngadi MO (2013) Binding of curcumin to b-lactoglobulin and its effect on antioxidant characteristics of curcumin. Food Chem 141: 1504-1511.
14. Prasad S, Tyagi AK, Aggarwal BB (2014) Recent developments in delivery, bioavailability, absorption and metabolism of curcumin: the golden pigment from golden spice. Cancer Res Treat 46(1): 2-18.
15. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB (2007) Bioavailability of curcumin: problems and promises. Mol Pharm 4(6): 807-818.
16. Lu Y, Du SY, Chen XL, Wu Q, Song X, et al. (2011) Enhancing effect of natural borneol on the absorption of geniposide in rat via intranasal administration. J Zhejiang Univ Sci B 12: 143-148.
17. 125I-cobrotoxin after intranasal administration to the brain: a microdialysis study in freely moving rats. Int J Pharmaceut 328: 161-167.
18. Cai Z, Hou SX, Li YB, Zhao BB, Yang ZX, et al. (2008) Effect of borneol on the distribution of gastrodin to the brain in mice via oral administration. J Drug Target 16(2): 178-184. (Pubitemid 351266554)
19. Dai JP, Chen J, Bei YF, Han BX, Wang S (2009) Influence of borneol on primary mice oral fibroblasts: a penetration enhancer may be used in oral submucous fibrosis. J Oral Pathol Med 38: 276-281.
20. Zhou Y, Li W, Chen L, Ma S, Ping L, et al. (2010) Enhancement of intestinal absorption of akebia saponin D by borneol and probenecid in situ and in vitro. Environ Toxicol Pharmacol 29: 229-234.
21. Shen Q, Li X, Li W, Zhao X (2011) Enhanced intestinal absorption of daidzein by borneol/menthol eutectic mixture and microemulsion. AAPS Pharm Sci Tech 12: 1044-1049.
22. Grossman D, Altieri DC (2001) Drug resistance in melanoma: Mechanisms, apoptosis, and new potential therapeutic targets. Cancer Metast Rev 20: 3-11. (Pubitemid 34074673)
23. Rigel DS, Carucci JA (2000) Malignant melanoma: prevention, early detection, and treatment in the 21st Century. CA-Cancer J Clin 50: 215-236. (Pubitemid 30654880)
24. Chen TF, Zheng WJ, Wong YS, Yang F (2008) Mitochondria-mediated apoptosis in human breast carcinoma MCF-7 cells induced by a novel selenadiazole derivative. Biomed Pharmacother 62: 77-84.
25. Tallarida RJ (2001) Drug synergism: its detection and applications. J Pharmacol Exp Ther 298: 865-872.
26. Kerr JF, Wyllie AH, Currie AR (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Brit J Cancer 26: 239-257.
27. Zou H, Henzel WJ, Liu XS, Lutschg A, Wang XD (1997) Apaf-1, a human protein homologous to C elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90: 405-413. (Pubitemid 27347231)
28. Banin S, Moyal L, Shieh SY, Taya Y, Anderson CW, et al. (1998) Enhanced phosphorylation of p53 by ATM in response to DNA Damage. Science 281: 1674-1677.
29. Roos WP, Kaina B (2006) DNA damage-induced cell death by apoptosis. Trend Mol Med 12: 440-448.
30. Roos WP, Kaina B (2013) DNA damage-induced cell death: from specific DNA lesions to the DNA damage response and apoptosis. Cancer Lett 332: 237-248.
31. Matsuoka S, Ballif BA, Smogorzewska A, Robert McDonald III E, Hurov KE, et al. (2007) ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 316: 1160-1166. (Pubitemid 46877472)
32. Cortez D, Wang Y, Qin J, Elledge SJ (1999) Requirement of ATM-dependent phosphorylation of Brca1 in the DNA damage response to double-strand breaks. Science 286: 1162-1166.
33. Shieh SY, Ikeda M, Taya Y, Prives C (1997) DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91: 325-334. (Pubitemid 27467963)
34. Chen TF, Wong YS (2008) Selenocystine induces S-phase arrest and apoptosis in human breast adenocarcinoma MCF-7 cells by modulating ERK and Akt phosphorylation. J Agric Food Chem 56: 10574-10581.
35. Boldt S, Weidleand UH, Kolch W (2002) The role of MAPK pathways in the action of chemotherapeutic drugs. Carcinogenesis 23: 1831-1838. (Pubitemid 35355933)
36. Sakaguchi K, Herrera JE, Saito S, Miki T, Bustin M, et al. (1998) DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev 12: 2831-2841. (Pubitemid 28440142)
37. Abrams SL, Steelman LS, Shelton JG, Wong EWT, Chappell WH, et al. (2010) The Raf/MEK/ERK pathway can govern drug resistance, apoptosis and sensitivity to targe -ted therapy. Cell Cycle 9: 1781-1791.
38. Cho HJ, Suh DS, Moon SH, Song YJ, Yoon MS, et al. (2013) Silibinin inhibits tumor growth through downregulation of extracellular signal-regulated kinase and akt in vitro and in vivo in human ovarian cancer cells. J Agric Food Chem 61: 4089-4096.
39. Huang AC, Chang CL, Yu CS, Chen PY, Yang JS, et al. (2013) Induction of apoptosis by curcumin in murine myelomonocytic leukemia WEHI-3 cells is mediated via endoplasmic reticulum stress and mitochondria-dependent pathways. Environ Toxicol 28: 255-266.
40. Manning BD, Cantley LC (2007) AKT/PKB signaling: navigating downstream. Cell 129: 1261-1274. (Pubitemid 46962095)
41. Chen TF, Wong YS (2008) Selenocystine induces apoptosis of A375 human melanoma cells by activating ROS-mediated mitochondrial pathway and p53 phosphorylation. Cell Mol Life Sci 65: 2763-2775.
42. Circu ML, Aw TY (2010) Reactive oxygen species, cellular redox systems, and apoptosis Free Radical Bio Med 48: 749-762.
43. Pelicano H, Carney D, Huang P (2004) ROS stress in cancer cells and therapeutic implications. Drug Resist Update 7: 97-110. (Pubitemid 38736063)
44. Martindale JL, Holbrook NJ (2002) Cellular response to oxidative stress: Signaling for suicide and survival. J Cell Physiol 192: 1-15. (Pubitemid 34587382)
45. Yang HY, Kim J, Chung GH, Lee JC, Jang YS (2007) Cross-linking of MHC class II molecules interferes with phorbol 12,13-dibutyrate-induced differentiation of resting B cells by inhibiting Rac-associated ROS-dependent ERK/p38 MAP kinase pathways leading to NF-k B activation. Mol Immunol 44: 1577-1586.
46. Su YT, Chang HL, Shyue SK, Hsu SL (2005) Emodin induces apoptosis in human lung adenocarcinoma cells through a reactive oxygen species-dependent mitochondrial signaling pathway. Biochem Pharmacol 70: 229-241.
47. Sharma RA, Gescher AJ, Steward WP (2005) Curcumin: the story so far. Eur J Cancer 41: 1955-1968. (Pubitemid 41557681)